FDA recalls 300,000 Teva blood pressure patches over unapproved ingredient

The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health ...
Business Wire

Tris Pharma’s Once-Daily ADHD Medication, ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, Now Available in the United States

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Medscape

FDA Approves Extended-Release Clonidine for Pediatric ADHD

October 7, 2010 — The US Food and Drug Administration (FDA) has approved clonidine hydrochloride, 0.1-mg and 0.2-mg, extended-release tablets (Kapvay; Shionogi Inc ...

FDA recalls 300,000 cartons of Teva blood pressure patches over unapproved ingredient

The U.S. Food and Drug Administration classified a Teva Pharmaceuticals recall of about 300,133 clonidine transdermal patch ...